Areej Alowfi

Dr. Areej Alowfi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
AAAreej Alowfi
Areej Alowfi
SBSumayah Binladen
Sumayah Binladen
SISumaya Irqsous
Sumaya Irqsous
AKAlya Khashoggi
Alya Khashoggi
MKMuhammad Anwar Khan
Muhammad Anwar Khan
RCRamah Calacattawi
Ramah Calacattawi
Background: Metabolic syndrome (MS) has become one of the major challenges to public health worldwide due to its significant association with increased risk of developing type 2 diabetes and cardiovascular disease (CVD) among children and adolescents. Therefore, this study aims to determine the prevalence and risk factors of MS in Saudi adolescents. Methods: This cross-sectional study was conducted in two female National Guard schools (Um Kalthoom Intermediate School and Zainab Bint Jahsh Secondary School) in Jeddah, Saudi Arabia, between January 2018 and March 2018. Of the 808 female students, 172 (age range of 12–19 years) participated voluntarily, with consent from their guardian(s), fasted for at least 8 h prior to the study, and represent the final study sample. Male students were not included due to cultural constraints in conducting the study. Demographic data, physical measurement (blood pressure, weight, height, body mass index (BMI) and waist circumference (WC)), and biochemical measurement (fasting plasma glucose and triglycerides, high-density lipoprotein (HDL), and low-density lipoprotein) were obtained. The International Diabetes Federation (IDF) criteria was utilized in the diagnosis of MS. Results: Of the 172 female adolescents, 24 (13.75%) are overweight, 20 (11.63%) are obese, and 3 (1.74%) are underweight. High-fasting plasma glucose (n = 85, 49.41%) and high waist circumference (n = 74, 43.02%) were the most common risk factors of MS among female adolescents. The overall prevalence of MS was 7% (n = 12/172). MS is more common among those who are obese or among those with a BMI that falls at the ≥95th percentile (n = 6/20, 30.0%) (p < 0.05) as compared to those who are overweight with a BMI that falls within the 85th to <95th percentiles (n = 2/24, 8.33%). Interestingly, 3.20% of the sample (n = 4/125) with normal BMI were diagnosed with MS. Conclusions: Our study indicates that MS is common among obese and overweight female adolescents but is also present among those who are not obese or with normal BMI. Moreover, the prevalence of overweight, obese, and those with MS in this reference population are lower compared to the cities of Makkah and Riyadh; however, it varies widely around the world due to different criteria and cut-off values in the diagnosis of MS.

23 April 2026 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
AAAsmaa Mohammad Alrefaie
Asmaa Mohammad Alrefaie
DADanah Mohamed Alghamdi
Danah Mohamed Alghamdi
RAReema Abdulaziz Alghamdi
Reema Abdulaziz Alghamdi
WAWejdan Talal Almutairi
Wejdan Talal Almutairi
RBRenad Nasser Balubaid
Renad Nasser Balubaid
AAAreej Alowfi
Areej Alowfi
Introduction: Iron deficiency anemia (IDA) is one of the most common nutritional deficiencies in infants and can significantly impact cognitive and physical development if left untreated. This study aimed to estimate the prevalence of IDA among infants aged 6 to 18 months attending well-baby clinics at primary health care centers (PHCCs) in City, Saudi Arabia, and to assess associated demographic and clinical factors. Methods: A cross-sectional study was conducted from May 2022 to April 2023 across 3 PHCCs in the City. Infants aged 6 to 18 months presenting for routine vaccination were included through non-probability consecutive sampling. Data were extracted from the electronic health record system, including demographic details, laboratory values (Hgb, MCV, MCH, RDW, and serum ferritin), and management records. IDA was defined as low hemoglobin, low MCV, and high RDW, or low hemoglobin plus low ferritin. Statistical analyses were performed using RStudio with significance set at P < .05. Results: Of 1,827 infants included, 732 (40.1%) had laboratory screening data available. The median age was 10.0 months, and 50.5% were male. IDA was identified in 38 infants (5.2%; 95% CI: 3.8%-7.0%). Male infants had a significantly higher prevalence of IDA than females (7.6% vs 2.3%, P = .005). No significant differences in IDA prevalence were found across PHC centers ( P = .173) or by age group ( P = .537). Proper management documentation was available for 113 infants, with 61.1% receiving appropriate care. Conclusion: The study found a moderate prevalence of IDA among infants aged 6 to 18 months, with male infants at significantly higher risk. The findings highlight the need for improved routine screening and follow-up management, particularly among high-risk subgroups, to prevent long-term developmental complications associated with iron deficiency anemia.